Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Mode of delivery and postpartum morbidity in Latin American and Caribbean countries among women who are infected with human immunodeficiency virus-1: the NICHD International Site Development Initiative (NISDI) Perinatal Study.

Duarte G, Read JS, Gonin R, Freimanis L, Ivalo S, Melo VH, Marcolin A, Mayoral C, Ceriotto M, de Souza R, Cardoso E, Harris DR; NISDI Perinatal Study Group.

Am J Obstet Gynecol. 2006 Jul;195(1):215-29. Epub 2006 May 3.

PMID:
16677591
2.

Multiple cesarean section morbidity.

Makoha FW, Felimban HM, Fathuddien MA, Roomi F, Ghabra T.

Int J Gynaecol Obstet. 2004 Dec;87(3):227-32.

PMID:
15548394
3.

Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery.

Fiore S, Newell ML, Thorne C; European HIV in Obstetrics Group.

AIDS. 2004 Apr 9;18(6):933-8.

PMID:
15060441
4.

Maternal morbidity associated with cesarean delivery without labor compared with spontaneous onset of labor at term.

Allen VM, O'Connell CM, Liston RM, Baskett TF.

Obstet Gynecol. 2003 Sep;102(3):477-82.

PMID:
12962927
5.

Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

Burdge DR, Money DM, Forbes JC, Walmsley SL, Smaill FM, Boucher M, Samson LM, Steben M; Canadian HIV Trials Network Working Group on Vertical HIV Transmission.

CMAJ. 2003 Jun 24;168(13):1671-4. No abstract available.

6.

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Mofenson LM; Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.

MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.

7.

Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery.

Marcollet A, Goffinet F, Firtion G, Pannier E, Le Bret T, Brival ML, Mandelbrot L.

Am J Obstet Gynecol. 2002 Apr;186(4):784-9.

PMID:
11967508
8.

Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures.

Grubert TA, Reindell D, Kästner R, Belohradsky BH, Gürtler L, Stauber M, Dathe O.

Clin Infect Dis. 2002 Mar 15;34(6):822-30. Epub 2002 Feb 11.

PMID:
11850864
9.
10.

Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women.

Rodriguez EJ, Spann C, Jamieson D, Lindsay M.

Am J Obstet Gynecol. 2001 May;184(6):1108-11.

PMID:
11349171
11.

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study.

Read JS, Tuomala R, Kpamegan E, Zorrilla C, Landesman S, Brown G, Vajaranant M, Hammill H, Thompson B; Women and Infants Transmission Study Group.

J Acquir Immune Defic Syndr. 2001 Mar 1;26(3):236-45.

PMID:
11242196
12.

Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL.

Watts DH, Lambert JS, Stiehm ER, Bethel J, Whitehouse J, Fowler MG, Read J.

Am J Obstet Gynecol. 2000 Jul;183(1):100-7.

PMID:
10920316
13.

Maternal complications after caesarean section in HIV infected women.

Vimercati A, Greco P, Loverro G, Lopalco PL, Pansini V, Selvaggi L.

Eur J Obstet Gynecol Reprod Biol. 2000 May;90(1):73-6.

PMID:
10767514
14.

Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment.

Grubert TA, Reindell D, Kästner R, Lutz-Friedrich R, Belohradsky BH, Dathe O.

Lancet. 1999 Nov 6;354(9190):1612-3.

PMID:
10560681
15.

Post-cesarean section morbidity in HIV-positive women.

Maiques-Montesinos V, Cervera-Sanchez J, Bellver-Pradas J, Abad-Carrascosa A, Serra-Serra V.

Acta Obstet Gynecol Scand. 1999 Oct;78(9):789-92.

PMID:
10535342
16.

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.

European Mode of Delivery Collaboration.

Lancet. 1999 Mar 27;353(9158):1035-9. Erratum in: Lancet 1999 May 15;353(9165):1714.

PMID:
10199349
17.

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

International Perinatal HIV Group, Andiman W, Bryson Y, de Martino M, Fowler M, Harris D, Hutto C, Korber B, Kovacs A, Landesman S, Lindsay M, Lapointe N, Mandelbrot L, Newell M-L, Peavy H, Read J, Rudin C, Semprini A, Simonds R, Tuomala R.

N Engl J Med. 1999 Apr 1;340(13):977-87.

18.

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.

Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Bénifla JL, Delfraissy JF, Blanche S, Mayaux MJ.

JAMA. 1998 Jul 1;280(1):55-60.

PMID:
9660364
19.

Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.

Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper U, Irion O, Schüpbach J, Nadal D.

AIDS. 1998 Jan 22;12(2):205-10.

PMID:
9468370
20.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

Supplemental Content

Support Center